IP Library Granted Patent US 8,633,203
Granted Patent B2
US 8,633,203 · App. 12/849,600 · Granted Jan 21, 2014

Use of pterocarpans as active anti-cellulite ingredients

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,633,203
App. No.
12/849,600
Granted
Jan 21, 2014
Kind
B2
Abstract

The invention relates to a cosmetic, dermatological or pharmaceutical preparation, containing one, two or more compounds of formula (I) and/or a pharmaceutically acceptable salt of a compound of this type, (i) for use in a method for preventing, treating or reducing cellulite, and/or (ii) in an adequate quantity to reduce the lipid quantity contained in subcutaneous fat tissue, and/or to inhibit the differentiation of preadipocytes, and/or to inhibit the lipogenesis in adipocytes, wherein the radicals R1 to R8, independently of one another, signify hydrogen, hydroxy or C1-C4-alkoxy, and/or two adjacent radicals together form a methylenedioxy group.

Claims (18)

1. A cosmetic, dermatological, or pharmaceutical composition comprising:

(a) a Pao Rosa extract that has been treated with activated carbon comprising one or more compounds of formula (I),

wherein the radicals R1 to R8, independently of one another, are hydrogen, hydroxy or C1-C4-alkoxy, and/or two adjacent radicals together form a methylenedioxy group, and

wherein the total amount of the one or more compounds of formula (I) accounts for 0.001-1 wt. % of the composition, based on the total weight of the composition; and

(b) 0.005-10 wt. %, based on the total weight of the composition, of a lipolysis stimulant of formula (Xa),

wherein R9, R10 and R11, independently of one another, is hydrogen or methyl.

2. The composition according to claim 1 , wherein the radicals R1 to R8, independently of one another, are hydrogen, hydroxy, methoxy or ethoxy, and optionally one or more pairs of adjacent radicals in each case together form a methylenedioxy group.

3. The composition according to claim 1 , wherein at least one compound of formula (I) is a compound of formula (IA),

wherein the radical R3 is hydrogen, hydroxy or methoxy, and the radicals R6 and R7 together form a methylenedioxy group or, independently of one another, are hydrogen, hydroxy or methoxy.

4. The composition according to claim 1 , wherein the Pao Rosa extract comprises di-hydroxy-dimethoxy isoflavone, di-hydroxy-trimethoxy isoflavone, isoflavone, 2′,7-dihydroxy-4′,6-dimethoxyisoflavone, afrormosin, maackiain, and medicarpin.

5. The composition according to claim 1 , wherein the Pao Rosa extract comprises not more than 16% by weight of methoxylated isoflavones, based on the total dry mass of the Pao Rosa extract.

6. The composition according to claim 1 having photo-irritation factor of less than 5.

7. The composition according to claim 1 , wherein the total amount of Pao Rosa extract accounts for 0.001-5 wt. % of the composition, based on the total weight of the composition.

8. A cosmetic, dermatological, or pharmaceutical composition comprising:

(a) a compound of formula (B),

and

(b) 0.005-10 wt. %, based on the total weight of the composition, of a lipolysis stimulant of formula (Xa),

wherein R9, R10 and R11, independently of one another, is hydrogen or methyl.

Assignments (2)
MERGER Recorded Apr 22, 2011
From: SYMRISE GMBH & CO. KG
To: SYMRISE AG
Reel/Frame 026171/0582 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 12, 2010
From: MEYER, IMKE; KOCH, OSKAR; HILLEBRAND, NADINE; HERRMANN, MARTINA; JOPPE, HOLGER
To: SYMRISE GMBH & CO. KG
Reel/Frame 025127/0119 →